Carl Baldick Email & Phone Number | Accomplished scientist with experience in pharmaceutical research in the areas of infectious diseases, immunology, immuno-oncology, oncology, and rare diseases. Extensive background in target validation, plate-based assay development, high throughput screen (HTS) development, and hit-to-lead progression. Successful in advancing novel small molecules, antisense oligonucleotides, and antibody therapeutics. Effective leader and team contributor with a track record of applying scientific rigor and innovative approaches to drive portfolio value.

Carl Baldick

Accomplished scientist with experience in pharmaceutical research in the areas of infectious disease...
Greater Philadelphia, Greater Philadelphia, United States

*50 free lookup(s) per month.

No credit card required.

Carl Baldick’s Email joe.baldick@bms.com

Carl Baldick’s Phone Numbers

Get CARL’s Phone Number (For Free)

Social Media

Carl Baldick’s Location Greater Philadelphia, Greater Philadelphia, United States

Carl Baldick’s Current Industry Bristol Myers Squibb

Carl Baldick’s Prior Industry Wyeth | Princeton University

Not the Carl Baldick you were looking for?

Find accurate emails & phone numbers for over 700M professionals.

Work Experience

Bristol Myers Squibb

Director, Leads Discovery and Optimization

2022-04-01 00:00:00 - Present

Wyeth

Sr. Research Scientist

1998-01-01 00:00:00 - 2002-01-01 00:00:00

Princeton University

Postdoctoral Fellow

1993-01-01 00:00:00 - 1998-01-01 00:00:00

Skills

No Skills Available

Languages

No Languages Available

FAQ About Carl Baldick

Carl Baldick is located at
Greater Philadelphia, Greater Philadelphia, United States

Carl Baldick is a Accomplished scientist with experience in pharmaceutical research in the areas of infectious diseases, immunology, immuno-oncology, oncology, and rare diseases. Extensive background in target validation, plate-based assay development, high throughput screen (HTS) development, and hit-to-lead progression. Successful in advancing novel small molecules, antisense oligonucleotides, and antibody therapeutics. Effective leader and team contributor with a track record of applying scientific rigor and innovative approaches to drive portfolio value.